Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect

Description

Picomolar inhibitor of reverse transcriptase featuring

Approved HIV reverse transcriptase inhibitors in the past decade

The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside

Design and biological evaluation of cinnamic and phenylpropionic

Non-Nucleoside Reverse Transcriptase Inhibitors - an overview

Current scenario on non-nucleoside reverse transcriptase

The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside

PDF) Prevalence of predicted resistance to Doravirine in HIV-1

Pharmaceuticals, Free Full-Text

Picomolar inhibitor of reverse transcriptase featuring

Reverse transcriptase - ScienceDirect

Picomolar inhibitor of reverse transcriptase featuring

$ 13.00USD
Score 4.7(656)
In stock
Continue to book